medigraphic.com
ISSN 1561-3070 (Electronic)

2018, Number 4

<< Back Next >>

Rev Cub Oftal 2018; 31 (4)

Current management of endophtalmitis after the cataract surgery

Bauza FY, Veitía RZA, Cuan AY, Góngora TJC, Hernández LI

Language: Spanish
References: 28
Page: 45-53
PDF size: 207.68 Kb.


ABSTRACT

Endophtalmitis is a severe complication of the cataract surgery which all the eye surgeons and patients try to avoid. The visual loss that occurs in a great proportion of postoperative endophthalmitis can be serious and irreversible. One may suspect the existence of acute endophthalmitis when there is sudden reduction of visual acuity after cataract surgery, normally associated to pain and signs of diffuse ocular inflammation. The suspicion of endophthalmitis is a medical urgency that must be treated with intravitreous antibiotics and/or vitrectomy as soon as possible. Information search about this topic in the last ten years, its incidence, recommendations and preoperative management in its prophylaxis, clinical signs and symptoms and the germs that may frequently cause it as well as the treatment options was made in Informed platform, particularly in the Virtual Library of Health.


REFERENCES

  1. Merayo-Lloves J, Riestra AC, Galarreta D, Cordovés L, Alfonso JF. Manejo de la endoftalmitis en cirugía de cataratas. Barcelona: Ediciones Mayo; 2014.

  2. Yannuzzi NA, Si N, Relhan N, Kuriyan AE, Albini TA, Berrocal AM, et al. Endophthalmitis after clear corneal cataract surgery: outcomes over two decades. Am J Ophthalmol. 2017;174:155-9.

  3. Barry P, Cordovés L, Gardner S. ESCRS Guidelines for prevention and treatment of endophthalmitis following cataract surgery. Data, dilemmas and conclusions; 2013 [citado 20 de octubre de 2018]. Disponible en: http://www. escrs.org/downloads/Endophthalmitis-Guidelines.pdf

  4. Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978-88.

  5. World Health Organization. Blindness. 2012 [citado 20 de octubre de 2018]. Disponible en: http:// www.who.int/blindness/en/

  6. Cao H, Zhang L, Li L, Lo S. Risk factors for acute endophthalmitis following cataract surgery: a systematic review and metaanalysis. PLoSOne. 2013;8(8):e71731.

  7. Haripriya A, Chang DF, Namburar S. Efficacy of intracameral moxifloxacin endophthalmitis prophylaxis at Aravind Eye Hospital. Ophthalmology. 2016;123(2):302-8.

  8. Quiroga LP, Lansingh V, Laspina F, Samudio M, Stanley J, Kaspar HM, et al. A prospective study demonstrating the effect of 5 % povidone-iodine application for anterior segment intraocular surgery in Paraguay. Arq Bras Oftalmol. 2010;73:125-8.

  9. Behndig A, Cochener B, Guell JL, Kodjikian L, Mencucci R, Nuijts RM, et al. Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg. 2013;39:1421-31.

  10. Friling E, Lundstrom M, Stenevi U, Montan P. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg. 2013;39:15-21.

  11. Pathengay A, Flynn HW Jr, Isom RF, Miller D. Endophthalmitis outbreaks following cataract surgery: causative organisms, etiologies and visual acuity outcomes. J Cataract Refract Surg. 2012;38:1278-82.

  12. Gower EW, Lindsley K, Nanji AA, Leyngold I, McDonnell PJ. Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery. Cochrane Data base Syst Rev. 2017;13(2):CD006364.

  13. Garat M, Moser CL, Martín-Baranera M, Alonso-Tarrés C, Álvarez- Rubio L. Prophylactic intracameral cefazolin after cataract surgery: endophthalmitis risk reduction and safety results in a 6-year study. J Cataract Refract Surg. 2009;35:637-42.

  14. Romero-Aroca P, Méndez-Marín I, Salvat-Serra M, Fernández-Ballart J, Almena-García M, Reyes-Torres J. Results at seven years after the use of intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery. BMC Ophthalmol. 2012;12:2.

  15. Campagna JD, Bond MC, Schabelman E, Hayes BD. The use of cephalosporins in penicillin-allergic patients: a literature review. J Emerg Med. 2012;42(5):612-20.

  16. Matsuura K, Miyoshi T, Suto C, Akura J, Inoue Y. Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan. J Cataract Refract Surg. 2013;39(11):1702-6.

  17. Bispo PJ, Alfonso EC, Flynn HW, Miller D. Emerging 8-methoxyfluoroquinolone resistance among methicillin-susceptible Staphylococcus epidermidis isolates recovered from patients with endophthalmitis. J Clin Microbiol. 2013;51:2959-63.

  18. Major JC Jr, Engelbert M, Flynn HW Jr, Miller D, Smiddy WE, Davis JL. Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am J Ophthalmol. 2010;149(2):278-83.

  19. Harper T, Miller D, Flynn HW Jr. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative Staphylococcus endophthalmitis isolates. Ophthalmology. 2007;114:871-5.

  20. Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479-96.

  21. Wallin T, Parker J, Jin Y, Kefalopoulos G, Olson RJ. Cohort study of 27 cases of endophthalmitis at a single institution. J Cataract Refract Surg. 2005;31(4):735-41.

  22. Chung JL, Lim EH, Song SW, Kim BY, Lee JH, Mah FS, et al. Comparative intraocular penetration of 4 fluoroquinolones after topical instillation. Cornea. 2013;32(7):1046-51.

  23. Barry P, Gardner S, Seal D, Gettinby G, Lees F, Peterson M, et al. Clinical observations associated with proven and unproven cases in the ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery. J Cataract Refract Surg. 2009;35(9):1523-31.

  24. Seal D, Reischl U, Behr A, Ferrer C, Alio J, Koerner RJ, et al. Laboratory diagnosis of endophthalmitis: comparison of microbiology and molecular methods in the European Society of Cataract & Refractive Surgeons multicenter study and susceptibility testing. J Cataract Refract Surg. 2008;34(9):1439-50.

  25. Simunovic MP, Rush RB, Hunyor AP, Chang AA. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and postreatment outcomes. Br J Ophthalmol. 2012;96(6):862-6.

  26. Canadian Ophthalmological Society Cataract Surgery. Clinical Practice Guideline Expert Committee. Canadian Ophthalmological Society evidence-based clinical practice guidelines for cataract surgery in the adult eye. Can J Ophtalmol. 2008;43(Suppl. 1):7-57.

  27. Hernández Martínez R, Ramos López M, Velázquez Villares Y. Vitrectomía pars plana 23 G en la endoftalmitis aguda poscirugía de catarata. Rev Cubana Oftalmol. 2017 [citado 20 de octubre de 2018];30(1). Disponible en: scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21762017000100016

  28. Kuhn F, Gini G. Complete and early vitrectomy for endophthalmitis (CEVE) as today's alternative to the endophthalmitis vitrectomy study. In: Vitreo-retinal Surgery. Springer Berlin Heidelberg; 2007. p. 53-68.




2020     |     www.medigraphic.com